CONTESSA/NEOCON-F TRIAL: ASSESSING THE EFFECTIVENESS AND SAFETY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY FERTILITY-SPARING SURGERY IN FIGO 2018 STAGE IB2 CERVICAL CANCER

Category Primary study
JournalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Year 2022
This article has no abstract
Epistemonikos ID: 7ffa0e5494e3f90d84e60df4d9ea660b73f98cb6
First added on: Feb 15, 2025